"Well we are at the halfway point of Q 4 and not one bit of new info since the AGM, nada, nothing. I am starting to wonder if they have any idea when the 250 event will occure, when top line results will be available......"

Why do you think the plan has changed since the AGM? At AGM, there were about 200 events, accumulating at ~10-15 per month. At the AGM, Resverlogix anticipated reaching 250 events and end of dosing by end of year. We are not at end of year yet and according to the slide in the latest BIO-Europe slide deck from earlier this month, Resverlogix re-iterated that they still expect to hit 250 events and last dosing in late 2018 and top-line in Q1 2019. The plan hasn't changed. It sound like you are just impatient. Also, they did present the full baseline data for BETonMACE at AHA, which also counters your point of no new info since AGM.